| Hikma Pharmaceuticals Share Price | |||
|---|---|---|---|
| Price | 1,463.00 | Open | 1,470.00 |
| Bid | 1,468.00 | High | 1,471.00 |
| Ask | 1,469.00 | Low | 1,451.00 |
| Change | 7.00 (0.48%) | Close | 1,456.00 |
| Volume | 558,780 | ||
| Currency | GBX |
|---|---|
| Issue Country | GB |
| Shares in Issue | 212.02m |
| Market Cap | £3.10b |
| PE Ratio | 10.825 |
| EPS | 135.15011 |
| Year High | 2,146.00 |
|---|---|
| Year High Date | 12-Jun-2025 |
| Year Low | 1,187.00 |
| Year Low Date | 09-Mar-2026 |
| Dividend | 63.62268 |
| Yield | 4.349% |
| # Trades | 1,696 |
|---|---|
| Vol. Sold | 151,907 |
| Sold Value | £2.04m |
| Vol. Bought | 400,366 |
| Bought Value | £5.79m |
| Market Size | 500 |
| Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
|---|---|---|---|---|---|---|---|---|
| 10-Jun-26 | 15:27:55 | 1,462.00 | 19 | Unknown* | 1,468.00 | 1,469.00 | 277.78 | O Ordinary Delayed publication Was reported as OTC |
| 10-Jun-26 | 17:11:35 | 1,461.725 | 1,500 | Unknown* | 1,468.00 | 1,469.00 | 21.93k | O Ordinary Was reported as OTC |
| 10-Jun-26 | 16:47:07 | 1,459.953 | 3,855 | Buy* | 1,468.00 | 1,469.00 | 56.28k | O Ordinary |
| 10-Jun-26 | 16:35:23 | 1,463.00 | 8,894 | Buy* | 1,468.00 | 1,469.00 | 130.12k | O Ordinary Trade was executed as an SI |
| 10-Jun-26 | 16:35:23 | 1,463.00 | 150 | Buy* | 1,468.00 | 1,469.00 | 2,195 | O Ordinary Trade was executed as an SI |
| 10-Jun-26 | 16:35:23 | 1,463.00 | 7 | Buy* | 1,468.00 | 1,469.00 | 102.41 | O Ordinary Trade was executed as an SI |
| 10-Jun-26 | 16:35:23 | 1,463.00 | 119 | Buy* | 1,468.00 | 1,469.00 | 1,741 | O Ordinary Trade was executed as an SI |
| 10-Jun-26 | 16:35:23 | 1,463.00 | 147 | Buy* | 1,468.00 | 1,469.00 | 2,151 | O Ordinary Trade was executed as an SI |
| 10-Jun-26 | 16:35:23 | 1,463.00 | 682 | Buy* | 1,468.00 | 1,469.00 | 9,978 | O Ordinary Trade was executed as an SI |
| 10-Jun-26 | 16:35:23 | 1,463.00 | 758 | Buy* | 1,468.00 | 1,469.00 | 11.09k | O Ordinary Trade was executed as an SI |
| Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
|---|---|---|---|---|---|---|---|
| 02-Jun-26 | 01-Jun-26 | Transfer From | Mazen Darwazah held the position of Executive Vice Chairman at the time of this trade.Mazen Darwazah | 0.00 | 93,413 | 3,149,568 | |
| 02-Jun-26 | 01-Jun-26 | Transfer From | Said Darwazah held the position of CEO at the time of this trade.Said Darwazah | 0.00 | 111,573 | 14,856,091 | |
| 28-Apr-26 | 27-Apr-26 | Buy | Victoria Hull held the position of Chairman at the time of this trade.Victoria Hull | 1,376.00 | GBX | 0 | 3,214 |
| 11-Nov-25 | 07-Nov-25 | Buy | Said Darwazah held the position of Executive Chairman at the time of this trade.Said Darwazah | 1,541.00 | GBX | 70,000 | 14,744,518 |
| 11-Nov-25 | 07-Nov-25 | Buy | Said Darwazah held the position of Executive Chairman at the time of this trade.Said Darwazah | 1,589.00 | GBX | 60,000 | 14,744,518 |
Hikma is a global pharmaceutical company that manufactures high-quality generic medicines and makes them accessible to people who need them.